Active ShortageTier 3 — Critical

DANTROLENE SODIUM FOR INJECTION, USP

HIKMA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of DANTROLENE SODIUM FOR INJECTION, USP in Canada?

Yes. DANTROLENE SODIUM FOR INJECTION, USP 20MG has an active shortage reported to Health Canada (last updated October 19, 2026).

Why is DANTROLENE SODIUM FOR INJECTION, USP not available?

The reason the manufacturer reported: Demand increase for the drug.

When will DANTROLENE SODIUM FOR INJECTION, USP be available again?

The manufacturer's estimated resolution date is January 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Expected resolution~3 months remaining (estimate)

Affected strength20MG

Report last updated2026-10-19

Checked by MedShort2026-11-13

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Health Canada classes this as a Tier 3 shortage, its highest-impact category. If you rely on this medication, talk to your pharmacist or care team now rather than waiting for your supply to run low. This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2027-01-31

~3 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02529998

Strength

20MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

DANTROLENE SODIUM

Tier

Tier 3 — Critical

Last Updated

2026-10-19

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

DANTROLENE SODIUM FOR INJECTION, USP has 2 shortage/discontinuation reports on file — this is one of them.

2026-07-27

Resolved

Demand increase for the drug.

Other Products from HIKMA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION USP

9MG · DIN 02304341

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02459906

ATROPINE INJECTION BP

0.6MG · DIN 02432196

ATROPINE INJECTION BP

0.4MG · DIN 02432188

AZACITIDINE FOR INJECTION

100MG · DIN 02507668

BACLOFEN INJECTION

0.05MG · DIN 02457059